Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients undergoing elective coronary artery bypass graft surgery using cardiopulmonary bypass
Exclusion criteria
Exclusion criteria: LEFT VENTRICULAR EJECTION FRACTION LESS THAN 30% CARDIOMYOPATHY PRE EXISTING VALVULAR HEART DISEASE GRADE 4 DIASTOLIC DYSFUNCTION ATRIAL FIBRILLATION SIGNIFICANT PULMONARY DISEASES (EG.ILD,PTE..) EMERGENCY PROCEDURE OESOPHAGEAL PATHOLOGY
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate left ventricular diastolic function by measuring Peak flow velocity of early diastolic filling E Early diastolic mitral annulus velocity e using Transesophageal echocardiography(TEE) under sevoflurane or propofol based anaesthesia in patients undergoing Coronary artery bypass graft on cardiopulmonary bypass Timepoint: 48hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare other parameters of diastolic function between sevoflurane and propofol group ; Late diastolic filling(A), Deceleration time (DT) , Peak systolic flow velocity (S), Peak diastolic flow velocity (D), S/D ratio, Peak reversal atrial flow (Ar), Duration of reverse atrial flow (Ar dur), Late diastolic mitral annulus velocity(a’). To determine the Vasoactive inotropic Score (VIS ) between sevoflurane group and propofol group . To assess the duration of Mechanical ventilation & ICU stay between sevoflurane group and propofol group Timepoint: 7 days | — |
Countries
India
Contacts
ARMY HOSPITAL R AND R NEW DELHI